This website is for UK Healthcare Professionals only

Click the button above to connect with us and make an appointment with a RINVOQ® product specialist.

UC, ulcerative colitis.

1. RINVOQ® Summary of Product Characteristics.

UK-RNQG-220015. Date of preparation: July 2022

Adverse events should be reported. Reporting forms and information can be found at or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. 
Adverse events should also be reported to AbbVie on [email protected]